Trazodone is the most prescribed drug for insomnia in the United States, and it was never approved for that purpose. The FDA greenlit trazodone in 1981 as an antidepressant. Every single prescription written for sleep — and there were over 20.7 million of them in 2019 alone — is technically off-label. What your psychiatrist may not tell you is that the American Academy of Sleep Medicine explicitly recommends against using trazodone for insomnia, citing inadequate evidence and potential harms that outweigh the benefits. That is not a fringe opinion.
It is the official clinical guideline from the leading sleep medicine organization in the country. This matters deeply for anyone caring for a loved one with dementia or cognitive decline, because trazodone’s side effect profile includes next-day cognitive impairment, increased fall risk, and confusion — the exact problems dementia caregivers are already fighting. The 2023 American Geriatrics Society Beers Criteria lists trazodone as a “potentially inappropriate medication” in older adults for precisely these reasons. Yet it remains one of the most commonly handed out sleep aids in nursing homes and geriatric practices across America. This article will walk through the real evidence behind trazodone for sleep, why it became so popular despite weak clinical support, the side effects that often get glossed over in a ten-minute appointment, and what you should actually discuss with your doctor before accepting or continuing this prescription.
Table of Contents
- Why Is Trazodone Prescribed for Sleep When Guidelines Recommend Against It?
- How Trazodone Actually Works for Sleep — and Where It Falls Short
- Side Effects That Hit Older Adults and Dementia Patients Hardest
- Trazodone vs. Other Sleep Medications — Tradeoffs Worth Understanding
- Long-Term Use, Withdrawal, and the Trap of Sleep Dependence
- The Black Box Warning Most Sleep Prescriptions Gloss Over
- What to Ask Your Doctor Before Accepting a Trazodone Prescription
- Conclusion
- Frequently Asked Questions
Why Is Trazodone Prescribed for Sleep When Guidelines Recommend Against It?
The short answer is inertia, habit, and a pharmaceutical economics problem nobody wants to fix. Trazodone went generic decades ago. It costs pennies per pill. No pharmaceutical company has any financial incentive to fund the rigorous, large-scale clinical trials that would be needed to earn an FDA-approved insomnia indication — and if those trials produced negative results, it could actually hurt the revenue stream from the millions of prescriptions already being written. According to research published in Health Affairs Scholar, society spends hundreds of millions of dollars annually on trazodone for an indication with uncertain evidence, and nobody in the drug industry is motivated to clarify whether that spending is justified. The numbers tell a striking story.
In 2019, 73.7 percent of all trazodone prescriptions were written for insomnia and sleep disorders. Only 8.4 percent were for depression — the condition it was actually approved to treat. By 2023, trazodone had become the 21st most commonly prescribed medication in the entire country, with over 24 million prescriptions filled. It accounts for roughly 26 percent of all insomnia prescriptions in the U.S., ahead of zolpidem (Ambien) at 20 percent. doctors prescribe it because it is cheap, because it is not a controlled substance, and because they have been doing it for so long that it feels safe. The American College of Physicians, however, concluded there is “insufficient evidence” to support trazodone’s effectiveness for sleep outcomes. That is a significant gap between practice and evidence.
How Trazodone Actually Works for Sleep — and Where It Falls Short
Trazodone produces drowsiness by blocking three types of receptors in the brain: serotonin 5-HT2A receptors, histamine H1 receptors, and alpha-adrenergic receptors. At low doses — typically 25 to 100 mg at bedtime — this combination creates sedation without the full antidepressant effect, which requires much higher doses of 150 to 400 mg. In one study, trazodone reduced the time it took to fall asleep by 44 percent, from an average of 51 minutes down to 28.5 minutes, and increased total sleep time by about 54 minutes per night over five weeks. Those are real, measurable improvements. However, the drug has a half-life of only 3 to 6 hours, which means it clears the body relatively quickly.
This is useful for falling asleep but often insufficient for staying asleep through the entire night. If your loved one’s primary complaint is waking at 2 or 3 a.m. and being unable to return to sleep — a pattern extremely common in dementia — trazodone may not address the actual problem. There is also a paradox worth knowing about: doses above 100 mg can cause wakefulness or restlessness rather than sedation, because at higher doses the serotonin reuptake inhibition begins to dominate over the receptor-blocking effects. More is not better with this drug when sleep is the goal, and a well-meaning dose increase can backfire.
Side Effects That Hit Older Adults and Dementia Patients Hardest
The side effects of trazodone are particularly concerning for the populations most likely to receive it. Studies have shown that trazodone impairs next-day memory performance, equilibrium, and muscle endurance. For a 78-year-old with mild cognitive impairment, that next-morning grogginess is not just an inconvenience — it is a fall waiting to happen. Research has found that patients on trazodone have a higher risk of falls compared to those on other sleep medications, and falls are the leading cause of injury-related death in adults over 65. The Beers Criteria flags trazodone for older adults specifically because of fall risk and confusion, yet it remains a staple of geriatric prescribing. Hyponatremia — dangerously low sodium levels — is another risk that deserves more attention than it gets. Trazodone can trigger the syndrome of inappropriate antidiuretic hormone secretion (SIADH), which causes the body to retain too much water and dilute sodium in the blood.
This is especially likely in elderly patients and those taking diuretics, which describes a large portion of the older population. Symptoms of hyponatremia include confusion, headache, nausea, and in severe cases, seizures. In a dementia patient, the early signs of hyponatremia — disorientation, lethargy, increased confusion — can easily be mistaken for disease progression rather than a drug side effect. If your loved one’s cognitive function seems to have declined after starting trazodone, a simple blood sodium test is worth requesting. Cardiac risks also warrant a frank conversation. Clinical studies have identified that trazodone may be arrhythmogenic, with documented risks including QT prolongation, torsade de pointes, and ventricular tachycardia with syncope. These are not theoretical risks listed for legal protection — they are observed cardiac events. For older adults already managing heart conditions, this interaction profile matters.
Trazodone vs. Other Sleep Medications — Tradeoffs Worth Understanding
The reason trazodone became so dominant is partly by process of elimination. Benzodiazepines like temazepam and lorazepam work reliably for sleep but carry serious dependence risk, rebound insomnia, and increased fall risk — and they are explicitly inappropriate for older adults. Z-drugs like zolpidem (Ambien) and eszopiclone (Lunesta) were marketed as safer alternatives, but they turned out to carry their own risks of complex sleep behaviors, next-day impairment, and dependence. Trazodone looked appealing because it is not classified as addictive and carries lower dependence risk than both benzodiazepines and Z-drugs. For a prescriber trying to help an older patient sleep without writing a controlled substance prescription, trazodone felt like the least bad option. But “least bad” is not the same as “good.” The tradeoff is that trazodone has weaker evidence for actually working than several of the drugs it replaced.
You are trading a well-proven but risky sleep medication for a less risky but poorly proven one. For some patients, that tradeoff makes sense. For others — particularly those with existing cognitive impairment, cardiac conditions, or a history of falls — the risks of trazodone may be comparable to or worse than the alternatives. Cognitive behavioral therapy for insomnia (CBT-I) remains the first-line recommendation from virtually every major medical organization, and it has no drug side effects at all. It is harder to access, requires more effort, and does not come in a pill bottle, which is why it is underutilized. But if a sleep problem is serious enough to medicate, it is serious enough to at least attempt behavioral intervention first.
Long-Term Use, Withdrawal, and the Trap of Sleep Dependence
One of the selling points of trazodone is that it is not addictive in the way that benzodiazepines or Z-drugs are. This is true in a pharmacological sense — it does not produce the same tolerance escalation or compulsive drug-seeking behavior. But there is a meaningful difference between “not addictive” and “easy to stop.” Abrupt discontinuation of trazodone can cause rebound insomnia, irritability, sweating, and sleep disturbances. The NHS and addiction medicine specialists recommend gradual tapering over weeks to months, which tells you something about the body’s adaptation to this drug even when classical addiction is not present.
There is also a subtler trap. Long-term reliance on trazodone may disrupt natural sleep architecture, making it progressively harder to sleep without the drug over time. The brain adjusts to the receptor blockade, and when the drug is removed, the sleep system that was being artificially managed now has to recalibrate. For a dementia caregiver who started their loved one on trazodone three years ago, the question “what happens if we stop?” can feel daunting — and the answer is often weeks of worse sleep before things stabilize. This creates a cycle where the drug becomes difficult to discontinue not because of addiction, but because the withdrawal period is genuinely unpleasant and, for an elderly person with cognitive decline, potentially destabilizing.
The Black Box Warning Most Sleep Prescriptions Gloss Over
Trazodone carries an FDA black box warning — the most serious type of warning the agency issues — for increased risk of suicidal thoughts and behaviors in patients under 24, particularly during the first months of treatment or during dose changes. While this is most relevant for younger patients prescribed trazodone for depression rather than older adults using it for sleep, it matters in mixed-age caregiving households. If a younger family member has been prescribed trazodone for sleep — as increasingly happens with adults in their twenties dealing with insomnia — this warning should not be treated as routine fine print. Additionally, serotonin syndrome is a potentially life-threatening reaction that can occur when trazodone is combined with SSRIs, SNRIs, triptans, MAOIs, lithium, fentanyl, St.
John’s wort, or tryptophan. Given that many patients taking trazodone for sleep are also on antidepressants, this combination risk is not hypothetical — it is an everyday prescribing scenario that requires careful monitoring. Priapism — a painful, prolonged erection lasting more than four hours — affects roughly 1 in 1,000 to 1 in 10,000 male patients taking trazodone. It constitutes a medical emergency requiring immediate treatment, potentially including surgery. This side effect is often mentioned quickly or not at all during prescribing conversations, but for male patients, it is worth knowing about before starting the medication rather than after an emergency room visit.
What to Ask Your Doctor Before Accepting a Trazodone Prescription
The goal is not to demonize trazodone or to suggest that nobody should take it. For some people, at some doses, in some circumstances, it provides meaningful help with sleep onset — and the evidence, while insufficient for a formal recommendation, does show real effects in controlled studies.
The goal is informed consent. Nearly 20 percent of Americans with insomnia are prescribed trazodone, and many of them have never been told that the drug is not approved for sleep, that the leading sleep medicine organization recommends against it, or that the evidence base is thin because no one has a financial reason to study it properly. If you are a caregiver managing sleep problems in a loved one with dementia, ask your prescribing doctor three specific questions: Has the patient been screened for sleep apnea or other treatable causes of insomnia? Has cognitive behavioral therapy for insomnia been considered? And what is the plan for reassessing whether this medication is still needed in three to six months? Trazodone should be a tool, not a default — and you deserve a prescriber who treats it that way.
Conclusion
Trazodone occupies a strange place in American medicine: the most prescribed insomnia drug in the country, recommended against by the leading sleep medicine organization, never approved by the FDA for the condition it most often treats, and backed by evidence too thin to satisfy any major clinical guideline. For older adults and people with dementia, the stakes are higher because the side effects — cognitive impairment, falls, confusion, cardiac risks, hyponatremia — overlap precisely with the vulnerabilities these patients already carry. The financial reality that no company will fund proper trials means this evidence gap is unlikely to close anytime soon. None of this means trazodone is poison or that everyone taking it should stop tomorrow.
It means the conversation around this drug needs to be more honest than it typically is. If your loved one is on trazodone for sleep, make sure you and their doctor have weighed the real risks against the modest and uncertain benefits, have considered non-drug alternatives, and have a plan for periodic reassessment. Sleep matters enormously for brain health and dementia care. The solution to a sleep problem should not create new problems of its own.
Frequently Asked Questions
Is trazodone safe for elderly dementia patients?
The 2023 American Geriatrics Society Beers Criteria lists trazodone as “potentially inappropriate” for older adults due to fall risk and confusion. It is not automatically unsafe, but it requires careful risk-benefit analysis with a knowledgeable prescriber, especially in patients who already have balance problems or cognitive impairment.
Can trazodone make dementia symptoms worse?
Studies show trazodone impairs next-day memory performance and equilibrium. In a patient with existing cognitive decline, these effects can mimic or accelerate apparent disease progression. If cognition seems to worsen after starting trazodone, discuss this with the prescribing doctor — it may be a drug effect, not disease advancement.
How long does trazodone take to work for sleep?
Trazodone typically induces drowsiness within 30 to 60 minutes at bedtime doses of 25 to 100 mg. However, its short half-life of 3 to 6 hours means it may help with falling asleep but not with staying asleep through the night.
Is trazodone addictive?
Trazodone is not classified as addictive and carries lower dependence risk than benzodiazepines or Z-drugs like Ambien. However, stopping abruptly can cause rebound insomnia, irritability, and sweating. Gradual tapering over weeks to months is recommended if discontinuing.
Why do doctors prescribe trazodone for sleep if guidelines recommend against it?
Trazodone is inexpensive, generic, not a controlled substance, and has been used off-label for sleep for decades. Doctors often prescribe it because alternatives carry worse side effect profiles or dependence risks. The lack of industry-funded trials means the evidence gap persists — not because the drug was proven ineffective, but because no one has invested in proving it effective.
What should I try before trazodone for sleep problems?
Cognitive behavioral therapy for insomnia (CBT-I) is the first-line recommendation from major medical organizations. Addressing sleep hygiene, treating underlying conditions like sleep apnea, managing pain, and establishing consistent routines should all be attempted before or alongside any sleep medication.
